Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

This is the protocol for a review and there is no abstract. The objectives are as follows: The primary objective is to review the evidence from two kinds of trials: (i) The effects of interventions specifically designed to limit weight gain on two outcomes: weight gain and smoking cessation. (ii) The effects of antidepressants, nicotine replacement therapy and exercise interventions on weight gain. For weight gain in (i) and (ii), the effects will be examined only in those with sustained abstinence from smoking. Secondary ojectives include: (i) The effects of the interventions on weight gain and smoking cessation at the end of the programme and at least six months postcessation, to determine whether any effects on weight gain and cessation are temporary. (ii) To examine evidence of interactions between body characteristics, gender, and psychological variables such as fear of weight gain on (a) smoking cessation and (b) weight gain. Copyright © 2006 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Original publication

DOI

10.1002/14651858.CD006219

Type

Journal article

Journal

Cochrane Database of Systematic Reviews

Publication Date

01/12/2006